Rebound Weight Gain After Stopping Tirzepatide (Mounjaro or Zepbound)
| GoalBMI Wellness Wellness Insights Physician-Reviewed Medical Content |
Rebound Weight Gain After Stopping Tirzepatide (Mounjaro or Zepbound)
| Author Sergey Terushkin, MD, FACS | Medically Reviewed By Dr. Sergey Terushkin, MD, FACS Last Reviewed: July 2026 | Sources SURMOUNT-4 Trial, JAMA, NIH, FDA, Oxford University Study 2026 |
If you have been taking tirzepatide whether as Mounjaro or Zepbound and you are thinking about stopping, one of the first questions you probably have is: will I gain the weight back? It is a completely reasonable concern. And the honest answer is that for most people, some weight regain is likely if treatment ends without a plan in place.
That does not mean stopping is always the wrong choice. People stop tirzepatide for many reasons cost, insurance changes, medication shortages, reaching a goal weight, pregnancy planning, or simply wanting to try maintaining results on their own. Understanding what to expect and how to give yourself the best chance of keeping the weight off makes a significant difference.
This guide covers what clinical trial data actually shows about weight regain after stopping tirzepatide, why it happens, how fast it tends to occur, and what you can do to protect your progress.
Related: Tirzepatide Side Effects: Complete Patient Guide
Quick Answer
Yes most people who stop tirzepatide do regain a portion of the weight they lost. The SURMOUNT-4 clinical trial found that 82.5% of participants who stopped tirzepatide regained at least 25% of their lost weight within one year. Weight regain typically begins within the first few weeks and can continue for up to 18 months. The good news is that with the right plan combining dietary habits, physical activity, and continued medical support many patients are able to maintain a meaningful portion of their results.
Quick Facts
| Topic | Details |
| Medication Names | Tirzepatide sold as Mounjaro (diabetes) and Zepbound (weight loss) |
| What Happens When You Stop | Appetite returns, digestion speeds up, weight regain begins for most patients |
| How Much Weight Returns? | 82.5% of patients who stopped regained at least 25% of lost weight in 1 year (SURMOUNT-4) |
| How Fast? | Average 0.8 kg (1.7 lbs) per month return to baseline weight within ~18 months without intervention |
| How Long Does It Stay in Your Body? | Half-life of approximately 5 days effects fade over 4-6 weeks after last dose |
| Can You Restart? | Yes most patients can restart tirzepatide if clinically appropriate |
| Best Way to Maintain Results | Dietary habits, physical activity, and continued medical monitoring |
| GoalBMI Support | Telehealth follow-up and weight maintenance programs available throughout New York |
Why Does Weight Come Back After Stopping Tirzepatide?
Rebound weight gain after stopping tirzepatide is not a failure of willpower. It is a predictable biological response that reflects how the medication works and how obesity functions as a chronic medical condition.
Appetite Returns
Tirzepatide works by activating GLP-1 and GIP receptors in the brain and digestive system, producing strong signals of fullness and appetite suppression. When the medication leaves the body, those signals fade. Hunger returns often quickly and noticeably and many patients find they feel the same level of appetite they had before starting treatment.
Digestion Speeds Up Again
One of tirzepatide’s key mechanisms is slowing gastric emptying the rate at which food moves from the stomach into the small intestine. This is what creates prolonged feelings of fullness after meals. When tirzepatide is stopped, gastric emptying returns to its normal rate, meals feel less satisfying, and patients naturally eat more to feel full.
Metabolic Adaptation
During significant weight loss, the body adapts by lowering its resting metabolic rate. When tirzepatide is stopped, patients are left with a reduced metabolism alongside returning appetite a combination that makes weight regain even more likely without deliberate lifestyle strategies in place.
Obesity Is a Chronic Condition
Obesity is recognized by the American Medical Association, the Obesity Medicine Association, and the NIH as a chronic, relapsing disease not a lifestyle failure. Just as patients with high blood pressure or high cholesterol often need long-term medication, patients with obesity may benefit from long-term medical treatment. Stopping tirzepatide without an alternative management strategy in place often leads to a return toward previous weight.
Clinical Insight Dr. Sergey Terushkin, MD, FACS
“What we see in clinical practice mirrors what the trials show. When patients stop tirzepatide, weight comes back for the majority not because they are doing anything wrong, but because the biological environment that drives weight regain is restored when the medication is removed. Our job is to help patients plan for that reality, not be surprised by it.”
What the Clinical Trials Show
Multiple large clinical studies have examined what happens when patients stop tirzepatide. The data is consistent: weight regain is common, often significant, and tends to occur relatively quickly.
The SURMOUNT-4 Trial The Most Important Study
The SURMOUNT-4 randomized clinical trial is the most comprehensive study examining what happens when patients stop tirzepatide. Published in JAMA, the trial followed patients who had already lost an average of 20% of their body weight over 36 weeks on tirzepatide.
After the initial weight loss period, patients were split into two groups:
- Group 1 Continued tirzepatide: Lost an additional 5.5% of body weight over the next 52 weeks
- Group 2 Switched to placebo (stopped tirzepatide): Regained 14% of their body weight over the next 52 weeks
A follow-up analysis published in JAMA Internal Medicine in November 2025 added an important detail:
82.5% of participants who stopped tirzepatide regained at least 25% of their lost weight within one year. Higher weight regain was associated with reversal of improvements in blood pressure, cholesterol, blood glucose, and insulin sensitivity.
University of Oxford Study 2026
A 2026 study from the University of Oxford, tracking patients who stopped semaglutide and tirzepatide in real-world conditions, found that:
- People who stopped tirzepatide regained an average of 0.8 kg (approximately 1.7 lbs) per month
- Return to baseline weight the weight before starting treatment occurred within approximately 18 months for most patients
- People losing 15 kg on tirzepatide gained nearly 10 kg back within the first year after stopping
Provider Perspective Karla K. Mioduchoski, FNP-BC
“The SURMOUNT-4 data was a turning point in how we counsel patients about tirzepatide. It confirmed what we were seeing clinically that stopping without a structured plan puts most patients at significant risk of regaining the majority of what they worked to lose. That is not a reason to avoid stopping it is a reason to plan carefully.”
| Study | Key Finding | Source |
| SURMOUNT-4 (JAMA) | 82.5% regained 25%+ of lost weight within 1 year of stopping | JAMA, 2023; JAMA Intern Med, 2025 |
| SURMOUNT-4 Continuation | Those who continued lost an additional 5.5% those who stopped regained 14% | Aronne et al., JAMA 2023 |
| Oxford University Study 2026 | Average 0.8 kg/month regain; return to baseline in ~18 months | West et al., 2026 |
| Drugs.com Analysis | Participants regained about 14% of lost weight within 1 year | Based on tirzepatide trial data |
Common Reasons People Stop Tirzepatide
There is no single reason patients stop tirzepatide. Understanding your reason for stopping can help your provider develop the most appropriate maintenance plan for your situation.
| Reason for Stopping | What This Means for Your Plan |
| Insurance coverage ending | Discuss alternative coverage options, compounded tirzepatide availability, or transition to a different GLP-1 with your provider |
| Cost concerns | Explore manufacturer savings programs (Eli Lilly savings card), telehealth pricing, or alternative medications |
| Medication shortage | Temporary pause restart plan should be in place with provider so treatment resumes quickly |
| Reached goal weight | Maintenance phase begins structured dietary and activity plan is essential; discuss continued low-dose treatment |
| Side effects | Most side effects improve over time discuss adjusting dose or escalation pace before stopping entirely |
| Pregnancy planning | Stop tirzepatide before trying to conceive work with your OB/GYN and weight loss provider on a safe plan |
| Wanting to try without medication | Realistic expectations and a structured maintenance plan are essential close monitoring recommended |
What Happens to Your Body When You Stop Tirzepatide
Week 1-2: Medication Begins Fading
Tirzepatide has a half-life of approximately 5 days. This means the medication remains active in the body for several weeks after the last injection. Most patients notice little immediate change in the first week or two.
Weeks 3-6: Appetite Begins Returning
As tirzepatide clears from the body, GLP-1 and GIP receptor activity returns to baseline. Patients typically begin noticing that they feel hungrier between meals, that portions that previously satisfied them no longer feel filling, and that food cravings particularly for higher-calorie foods begin to increase.
Month 2-3: Weight Regain Begins
Most patients begin to see the scale moving upward during the second and third month after stopping. Without the metabolic support of tirzepatide, caloric intake tends to increase while the body’s reduced metabolic rate (from weight loss) makes it easier to regain weight than to maintain it.
Month 6-18: Continued Regain Without Intervention
Without a structured maintenance plan, weight regain tends to continue gradually. The Oxford University 2026 study found that patients who stopped tirzepatide regained an average of 0.8 kg per month, with most returning to their pre-treatment baseline weight within approximately 18 months.
Health Markers Also Return
The SURMOUNT-4 analysis showed that it is not just weight that returns when tirzepatide is stopped. Improvements in blood pressure, cholesterol levels, blood glucose, and insulin sensitivity also reversed in patients who regained significant weight reinforcing that the health benefits of tirzepatide are tied to continued treatment.
How to Prevent Rebound Weight Gain After Stopping Tirzepatide
Weight regain is common but not inevitable. Patients who build strong lifestyle habits during their time on tirzepatide and who have a clear maintenance plan in place before stopping give themselves the best chance of preserving their results.
| Strategy | Why It Helps |
| Do not stop abruptly taper with your provider | Gradual dose reduction gives the body more time to adapt to lower medication levels before stopping completely |
| Build dietary habits before stopping | Patients who establish consistent eating patterns during treatment maintain more weight loss after stopping than those who relied primarily on the medication |
| Prioritize protein intake | Higher protein diets (1.2-1.6g per kg of body weight) help preserve muscle mass and support satiety without medication |
| Establish a consistent exercise routine | Resistance training in particular helps preserve muscle mass and supports a higher resting metabolic rate after weight loss |
| Track food intake during the transition | Many patients are unaware of how quickly portions increase when appetite returns tracking provides awareness and accountability |
| Schedule regular provider check-ins | Monthly weight monitoring in the first 6 months after stopping allows early intervention if significant regain begins |
| Consider a low-dose maintenance protocol | Some patients benefit from a reduced dose of tirzepatide for ongoing weight maintenance discuss this option with your provider |
| Address emotional eating patterns | Working with a registered dietitian or behavioral health specialist during the transition improves long-term outcomes |
Patient Education Tip Karla K. Mioduchoski, FNP-BC
“The patients who maintain the most weight loss after stopping tirzepatide are the ones who used their time on the medication to genuinely change their relationship with food and movement not just to lose weight. Tirzepatide makes it much easier to build those habits. The goal is to lock them in before the medication is no longer there to support you.”
Can You Restart Tirzepatide After Stopping?
Yes in most cases, patients can restart tirzepatide if clinically appropriate. If you stopped due to a temporary insurance lapse, medication shortage, cost issue, or pregnancy, restarting is often a viable option once those circumstances change.
Important: If you have been off tirzepatide for more than 4 weeks, do not simply resume the dose you were previously taking. Restarting typically requires going back to a starting dose and following the escalation schedule again. Jumping back to a higher dose after a long break significantly increases the risk of side effects.
What to Discuss With Your Provider Before Restarting
- How long you have been off the medication
- How much weight you have regained, if any
- Whether your insurance coverage has changed
- Any new health conditions or medications since stopping
- Whether Zepbound, Mounjaro, or a different GLP-1 is the right choice for your current situation
To discuss restarting tirzepatide with a GoalBMI Wellness provider, visit: tirzepatide New York
Rebound Weight Gain: Tirzepatide vs Semaglutide
Both tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) show significant weight regain after stopping. The comparison is informative for patients considering switching medications rather than stopping entirely.
| Factor | Tirzepatide (Mounjaro/Zepbound) | Semaglutide (Ozempic/Wegovy) |
| Average weight loss on medication | ~20-22% of body weight | ~12-15% of body weight |
| Weight regain after stopping | ~14% regained in 1 year (SURMOUNT-4) | ~2/3 of lost weight regained in 1 year |
| How fast weight returns | ~0.8 kg/month (Oxford 2026) | ~0.8 kg/month similar rate |
| Return to baseline weight | ~18 months without intervention | ~18 months without intervention |
| Health marker reversal | Blood pressure, glucose, cholesterol reverse with regain | Similar pattern observed |
| Half-life (how long it stays active) | ~5 days | ~1 week |
| Ability to restart | Yes, with dose escalation | Yes, with dose escalation |
Full comparison: Semaglutide vs Tirzepatide Complete Guide
Frequently Asked Questions
Do you gain weight back after stopping Mounjaro or Zepbound?
Yes most patients regain a portion of their lost weight after stopping tirzepatide. The SURMOUNT-4 clinical trial found that 82.5% of patients who stopped regained at least 25% of their lost weight within one year. Weight regain is not inevitable in full, and lifestyle habits established during treatment play a significant role in how much weight returns.
How fast does weight come back after stopping tirzepatide?
Weight regain typically begins within 3-6 weeks of stopping, once the medication has largely cleared from the body. A 2026 Oxford University study found patients regained an average of 0.8 kg (about 1.7 lbs) per month after stopping. Without intervention, most patients return to near their pre-treatment weight within approximately 18 months.
How long does tirzepatide stay in your body after stopping?
Tirzepatide has a half-life of approximately 5 days. This means roughly half of the medication is cleared from your body every 5 days after your last dose. Most of the pharmacological effects of tirzepatide particularly appetite suppression and gastric slowing fade noticeably within 3-6 weeks of the last injection.
Can I stop tirzepatide cold turkey or do I need to taper?
There is no strict medical requirement to taper tirzepatide it can be stopped abruptly without the withdrawal risks associated with some other medications. However, a gradual taper under provider guidance may help the body adjust more slowly and can make the transition easier to manage, particularly for patients concerned about rapid hunger return.
What is the best way to stop tirzepatide without gaining weight?
The most effective approach combines establishing strong dietary habits before stopping, increasing physical activity (especially resistance training), working with a provider on a transition plan, tracking food intake during the adjustment period, and scheduling regular weight monitoring appointments. No approach eliminates regain entirely, but these strategies significantly reduce how much weight returns.
Can I restart Mounjaro or Zepbound if I regain weight?
Yes if you experience significant weight regain after stopping tirzepatide and still meet the clinical criteria for treatment, restarting is generally an option. If you have been off the medication for more than 4 weeks, your provider will typically restart at a lower dose and follow the escalation schedule again rather than resuming your previous dose.
What happens to my blood pressure and blood sugar when I stop tirzepatide?
The SURMOUNT-4 follow-up analysis, published in JAMA Internal Medicine in 2025, found that weight regain after stopping tirzepatide was associated with reversal of improvements in blood pressure, blood glucose, cholesterol, and insulin sensitivity. Patients who managed to maintain more of their weight loss retained more of these health benefits as well.
Is rebound weight gain after tirzepatide the same as after semaglutide?
The rate and pattern of weight regain after stopping tirzepatide and semaglutide are broadly similar approximately 0.8 kg per month with return to baseline weight within about 18 months. Because tirzepatide typically produces greater initial weight loss, the absolute amount of weight regained can be larger even at the same percentage. Switching between GLP-1 medications rather than stopping entirely is an option worth discussing with your provider.
When to Contact Your Provider
Patients who have stopped tirzepatide should contact their GoalBMI Wellness provider if they experience:
- Significant weight regain particularly more than 5-10 lbs in the first few months after stopping
- Return of blood pressure, blood sugar, or cholesterol values that were previously improving on treatment
- Strong return of hunger or food cravings that are difficult to manage
- Questions about whether restarting tirzepatide or switching to a different medication is appropriate
- Difficulty maintaining dietary or lifestyle habits established during treatment
- Interest in a structured weight maintenance program with medical oversight
You do not have to wait until significant regain has occurred before reaching out. Early check-ins after stopping tirzepatide allow providers to intervene before a small amount of regain becomes a larger problem.
Schedule a follow-up at GoalBMI Wellness: Medical Weight Loss New York
Final Thoughts
Stopping tirzepatide does not have to mean giving back all the progress you made. The clinical data is honest weight regain is common for the majority of patients who stop without a plan. But the patients who do best are the ones who used their time on the medication to genuinely build healthier habits, who have a clear maintenance strategy in place before their last dose, and who stay connected with their healthcare team throughout the transition.
If you are thinking about stopping, talk to your GoalBMI Wellness provider before your last injection. That conversation is the most important step you can take.
From Our Medical Team Dr. Sergey Terushkin, MD, FACS
“We never encourage patients to stay on a medication longer than they need to or want to. But we always want the conversation about stopping to happen before the last dose not after the weight has started coming back. A 15-minute planning conversation can make the difference between maintaining most of your results and starting from scratch.”
Continue Reading at GoalBMI Wellness:
→ Tirzepatide Side Effects: Complete Patient Guide
→ Semaglutide vs Tirzepatide Which Is Right for You?
→ Tirzepatide Program New York
→ Semaglutide Program New York
→ Medical Weight Loss New York
→ Program Pricing & Insurance Verification
Medical References & Citations
This article was written using information from the following peer-reviewed studies, clinical trials, and authoritative medical sources:
Medical Review
| Author Sergey Terushkin, MD, FACS, Board-Certified Family Nurse Practitioner | Medically Reviewed By Dr. Sergey Terushkin, MD, FACS Board-Certified Surgeon & Medical Director Last Reviewed: July 2026 |
About GoalBMI Wellness
GoalBMI Wellness is a physician-guided telehealth platform providing medical weight loss, GLP-1 therapy, semaglutide programs, tirzepatide programs, peptide therapy, and wellness optimization services for eligible patients throughout New York. Patients do not need to visit a physical office. All consultations, prescriptions, and follow-ups are conducted remotely through secure telehealth appointments.
To learn more or schedule a consultation, visit wellness.goalbmi.com
Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical advice and should not replace consultation with a qualified healthcare provider. Treatment decisions, including the decision to stop or restart tirzepatide, should always be made in partnership with a licensed medical professional. Individual results vary, and no specific outcome is guaranteed.
-
Monday – Friday:: 9:00 AM – 8:00 PMSaturday:: 9:00 AM – 4:00 PMSunday:: 12:00 PM – 8:00 PM